Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
editas medicine
4
×
boston blog main
boston top stories
crispr
crispr-cas9
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
crispr therapeutics
gene editing
intellia therapeutics
national
advaxis
agios therapeutics
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
base editing
bio
biology
boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
breakup
bridge bio pharma
broad institute
cancer
cas13
ceo
clinical hold
clinical study
combination
commissioner
congress
What
cas
4
×
crispr
editing
gene
medicine
editas
argument
arguments
beam
begin
berkeley’s
big
bio
bosley's
bosley’s
bridge
bucks
cancer
cells
ceo
charpentier
colleague
court
crime
date
december
defect
departure
doudna
drive
edited
editor
emmanuelle
exit
fears
feng
flag
founders
genetic
gotten
Language
Current search:
cas
×
" editas medicine "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month